Press What’s news at AbelsonTaylor Group
Select category
What Pharma Can Teach Every Marketer About Risk, Regulation and Trust
In a guest post for the 4As, Eric Densmore, SVP of Business Strategy at AbelsonTaylor Group, explores what pharmaceutical marketing can teach every brand about navigating risk, regulation, and trust. Published October 17, 2025, the article examines how marketers can balance compliance with creativity, adapt to shifting FDA guidance, and build credibility in an environment where audiences are increasingly skeptical and information moves fast.
Read more: What Pharma Can Teach Every Marketer About Risk, Regulation and Trust
https://www.aaaa.org/blog/guest-post-what-pharma-can-teach-every-marketer-about-risk-regulation-and-trust/
Media Contact:
Recent Posts
The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.
As AI adoption accelerates, trust may be the real differentiator. In MedAdNews, Janet Barker-Evans, Chief Creative Officer of AbelsonTaylor Group,...
In the News Read more The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionRob Chartier Joins AbelsonTaylor Group as Director of Engagement Strategy
AbelsonTaylor Group today announced that Rob Chartier has joined the agency as Director of Engagement Strategy. Chartier brings more than...
Read Press Read more Rob Chartier Joins AbelsonTaylor Group as Director of Engagement StrategyConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.